Gritstone bio, Inc. Profile Avatar - Palmy Investing

Gritstone bio, Inc.

Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid t…

Biotechnology
US, EmeryVille [HQ]
Growth Rates · Payout · Yield

Dividends Over Time

  • Records
  • Forecasts [Soon]
Growth Rates
% YoY
% 3Yr
% 5Yr
% 10Yr
Key Metrics
- -% TTM Yield
- - Average Days Gap
Series
% - - Yield
0.00% Payout Ratio
Download
Cash Amount Pay Date
Download
Cash Amount Pay Date
End of GRTS's Analysis
CIK: 1656634 CUSIP: 39868T105 ISIN: US39868T1051 LEI: - UEI: -
Secondary Listings
GRTS has no secondary listings inside our databases.